Читать «Биологическая война (Часть 3)» онлайн - страница 284

Pollitzer R. Plague stud.es. 4. Pathology // Bull. World Hlth Org. 1952. V. 5. P. 337–376.

Pomerantsev A. P., Staritsyn N. A. Behavior of heteroiogous recombinant plasmid pCET in cells of Bacillus anthracis // Genetika 1996. V. 32. № 4. P. 500–509.

Pomerantsev A. P., Sukovatova L. V., Marinin L. I. Characterization of a Rif-R population of Bacillus anthracL // Antibiot. Khimioter. 1993. V. 38. № 8–9. P. 34–38.

Portnoy D., Faikow S. Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pest s // J. Bacteriol. 1981. V. 148. P. 877–883.

Powell A., Crozier J., Hodgson H. et al. A case of septicaemic anthrax in an intravenous drug user // В ViC Infectious Diseases, 2011 (http://www.biomedcentral com/1471-2334/11/21/).

Prabhu В. М., Ali S. F., Murdock R. C. et al. Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat // Nanotoxicol. 2010. V. 4. P. 150–160.

Pratt W. D., Gibbs P., Schmaljohn A. L. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infect.ons of Venezuelan equine encephalitis virus in non-human primates // Vaccine. 1998. V. 16. № 9-10. P. 1056–1064.

Price E. E., Seymour M. L., Sarovich D. S. et al. Molecular epidemiologic investigation of an anthrax outbreak among heroin useis, Europe // Emerg. Infect. Dis. 2012. V. 18. № 8. P.1307–1313.

Promdonkoy B., Ellar D. J. Membrane pore architecture of a cytolytic toxin from Bacillus thuringiensis Biochem J. 2000. V 350. P. 275–282.

Pugh C. W., Tabatabai L. B., BrickerB. J. et al. Immunogenicity of Brucella-extracted and recombinant protein vaccines in CD-I and BALB/c mice // Am. J. Vet. Res. 1990. V. 51. P. 1413–1120.

Rajamohan F., Alzate O., Cotrill J. A. et al. Protein engineering of Bacillus thuringiensis delta-endotoxin: mutations at domain 11 of Сгу1лЬ enhance receptor affinity and toxicity toward gypsy moth larvae // Proc. Natl. Acad. Sci. USA. 1996. V. 93. P. 14338-14343.

Ramos V., Vasconcelos V. Palytoxin and analogs: biological and ecological effects // Mar. Drugs. 2010. V. 8. P. 2021–2037

Ramsay C. N, Stirling A., Smith J. et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland // Eurosurveillance. 2010 V. 15. Is. 2 (14января).

Raoult D. Treatment of Q Fever // Antimicrob. Agents and Chemother. 1993. V. 37. № 9. P. 1733–1736.

Raoult D., Houpikian P., Tissot D. H et al. Treatment of Q fever endocarditis: comparison of 2 regimens con taimng doxycycline and ofloxacin or hydroxychloroqu.ne // Arch. Intern. Med. 1999. V. 159. № 2. P. 167–173.

Raoult D., Torres H., Drancourt. M Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii // Antimicrob. Agents Chemother. 1991. V. 35. P. 2077.

Raper S. E., Chirmule N., Lee F. S. et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylasc deficient patient following adenoviral gene transfer // Mol. Genet. Metab. 2003. V. 80 (1–2). P. 148–158.